Collaboration
pplk. RNDr. Michal Kroča, Ph.D.
Military Medical Agency, Military Health Institute, Biological Defence Department at Těchonín
Antitoxin therapy.
Petr Jansa PhD, Tomáš Cihlář PhD, Gabriel Birkuš PhD, Richard Mackman PhD
Gilead Sciences, Inc., Foster City, California, U.S.A.
Biological activity screening, pharmacokinetic profiles of active compounds and mutual general cooperation within Gilead Sciences & IOCB Research Centre.
Prof. Erik De Clercq, Prof. Jan Balzarini, Prof. Johan Neyts, Dr. Robert Snoeck, Dr. Lieve Naesens, Dr. Graciela Andrei
Rega Institute for Medical Research, Katholieke Universiteit Leuven, Belgium
Antiviral screening.
The School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, 4072 QLD, Australia
Antimalarial program.
Dr. Nicholas P. West,
The School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, 4072 QLD, Australia
Tuberculosis Research.
Mjr. Michael D. Edstein
Australian Army Malaria Institute, Enoggera, Brisbane, Queensland 4051, Australia
Antimalarial program.
Dr. Zdeněk Zídek
Institute of Experimental Medicine, Academy of Sciences of the Czech Republic
Immunomodulatory activity.
Dr. Helena Mertlíková-Kaiserová
IOCB Prague
Cytostatic activity, inhibitory activity towards thymidine phosphorylase.
IOCB Prague
NMR spectroscopy.
RNDr. Alena Panicucci Zíková, PhD.
Laboratory of Functional Biology of Protists, Institute of Parasitology, Biology Centre, ASCR, v.v.i.